← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 31, 2015Last known activity
Jan 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 2 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT06116539Lead sponsorPhase 1Jan 31, 2024
- NCT06116539Reponsible party - principal investigatorPhase 1Jan 31, 2024
- NCT06116539Study directorPhase 1Jan 31, 2024
- NCT03633292CollaboratorPhase 4Jan 31, 2015
Details
- Last known activity
- Jan 31, 2024